POLA1 and colorectal cancer: Of note, our data demonstrating increased sensitivity of ATR/CHK1 inhibitors in POLA1 depleted cells are strongly supported by already published data [35] showing synthetic lethality between CHK1 and B-family DNA polymerase including POLA1 in both lung and colorectal cancer cells.